Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Chanan-Khan, Asher Cramer, Paula Demirkan, Fatih Fraser, Graeme Silva, Rodrigo Santucci Grosicki, Sebastian Pristupa, Aleksander Janssens, Ann Mayer, Jiri Bartlett, Nancy L Dilhuydy, Marie-Sarah Pylypenko, Halyna Loscertales, Javier Avigdor, Abraham Rule, Simon Villa, Diego Samoilova, Olga Panagiotidis, Panagiots Goy, Andre Mato, Anthony HELIOS investigators Van Den Neste, Eric[UCL] (2016) The Lancet Oncology — Vol. 17, no. 2, p. 200-211 (2016)
- Journal article
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
Robak, Tadeusz Windyga, Jerzy Trelinski, Jacek von Depka Prondzinski, Mario Giagounidis, Aristoteles Doyen, Chantal[UCL] Janssens, Ann Álvarez-Román, María Teresa Jarque, Isidro Loscertales, Javier Pérez Rus, Gloria Hellmann, Andrzej Jêdrzejczak, Wiesław Wiktor Kuliczkowski, Kazimierz Golubovic, Lana M. Celeketic, Dusica Cucuianu, Andrei Gheorghita, Emanuil Lazaroiu, Mihaela Shpilberg, Ofer Attias, Dina> Karyagina, Elena (2012) Blood — Vol. 120, no. 18, p. 3670-3676 (2012)